hSSB1 (NABP2/OBFC2B) modulates the DNA damage and androgen‐induced transcriptional response in prostate cancer
Mark N. Adams(Queensland University of Technology), Derek J. Richard(Queensland University of Technology)
Cited by 13
Related Papers
Combination Therapy With Histone Deacetylase Inhibitors (HDACi) for the Treatment of Cancer: Achieving the Full Therapeutic Potential of HDACi
|Frontiers in Oncology|2018|655
The Emerging Role of Gas Plasma in Oncotherapy
|Trends in biotechnology|2018|130
Expression of CDCA3 Is a Prognostic Biomarker and Potential Therapeutic Target in Non–Small Cell Lung Cancer
|Journal of Thoracic Oncology|2017|84